WINT — Windtree Therapeutics Balance Sheet
0.000.00%
- $2.14m
- -$0.41m
- 11
- 58
- 13
- 17
Annual balance sheet for Windtree Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 22.6 | 16.9 | 22.3 | 6.17 | 4.32 |
Prepaid Expenses | |||||
Total Current Assets | 23.9 | 18.1 | 23.5 | 7.38 | 5.38 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.19 | 1.84 | 3.39 | 2.12 | 1.63 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 119 | 113 | 74.8 | 38 | 32.4 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.82 | 6.13 | 4.92 | 2.46 | 4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 44 | 43.3 | 32.9 | 27.9 | 29 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 74.9 | 69.6 | 41.9 | 10 | 3.39 |
Total Liabilities & Shareholders' Equity | 119 | 113 | 74.8 | 38 | 32.4 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |